Sacubitril/Valsartan (Chong Kun Dang Pharmaceutical)

沙库巴曲/缬沙坦 (Chong Kun Dang Pharmaceutical)

Report date: 2026/01/19 13:50:43

Base Information

Drug NameSacubitril/Valsartan (Chong Kun Dang Pharmaceutical)
Drug Alias NameCKD-202A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsNeprilysinAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A